INTRODUCTION AND OBJECTIVES: Current studies have failed to show clear long-term differences in oncologic outcomes or quality of life between Ileal Conduit (IC) and neobladder after Radical Cystectomy (RC). However, few studies have assessed cost differences between diversion types. We analyzed the differences in hospital costs during initial hospitalization and readmissions between neobladder and IC in a nationally representative sample.
METHODS: The 2013 Nationwide Readmissions Database (NRD) was queried for patients with bladder cancer undergoing RC. Sociodemographic characteristics, Length of Stay (LOS), hospital costs, and causes of readmission were compared between neobladder and IC. Univariable and multivariable logistic regression models were utilized to assess the impact of urinary diversion type on LOS, readmission rates, and hospitals costs. Costs were modeled using the gamma distribution to account for skewness of data.
RESULTS: Among 4,283 patients included in the analysis, 325 (7.5%) underwent neobladder reconstruction with the remainder undergoing IC. Patient's with a neobladder were younger (mean age 62 years vs. 69, p <0.001), had a lower Charlson Comorbidity Index (CCI) (CCI of 0 e 69%, vs. 47%, p<0.001), private insurance (44% vs. 24%, p <0.001), higher median household income (Top quartile e 35% vs. 24%, p¼ 0.02), and were more likely to be treated at high volume metropolitan teaching centers (High volume e 54% vs. 33%, p<0.001). Between the two groups, there was no difference in initial hospitalization LOS, readmission rate, readmission LOS, or 90-day mortality. Neobladders were more likely to be readmitted for hydronephrosis (2.7% vs. 0.3%, p < 0.001) and UTI/Pyelonephritis (18.9% vs. 11.4%, p ¼ 0.066) though the latter did not reach statistical significance. Neobladder mean costs were higher for the initial hospitalization and at 30-day and 90 days. At 90-days, neobladders cost on average $14,000 more per patient than IC. On multivariable analysis, neobladder was an independent predictor of increased cost during readmission (OR 3.41, p < 0.001).
CONCLUSIONS: Neobladder diversion after RC is more costly compared to IC both during initial admission and at 90-days despite similar LOS and readmission rates. The increased cost of care may be secondary to increased treatment for obstructive and infectious complications. In an era of changing reimbursements, cost of diversion may also need to be considered when selecting diversion type. is widely used to predict post-op morbidity and mortality in procedure specific models. No validation has been done of its accuracy for urologic surgeries. The goal of this study is to evaluate the ability of NSQIP surgical risk calculator to predict the 30-day complications, readmission, reoperation, and mortality after radical cystectomy for bladder cancer.
Source of Funding: None
METHODS: Medical records of all bladder cancer patients who underwent radical cystectomy between 2008 and 2015 were retrospectively reviewed. The data were collected according the NSQIP's definitions. NSQIP calculator was used to predict the probability of complications for these patients. NSQIPRC predicted complication rates were compared to the observed complication rates in our institute using c-statistics, the area under the receiver operating characteristic (ROC) curve, and Brier's score to measure the calibration and discrimination.
RESULTS: We identified 439 who underwent radical cystectomy for bladder cancer. One main weakness of the NSQIPRC is its inability of predicting gastroenterological and urinary tract complications, these complications occurred in 136 (30%) and 49 (11%) patients respectively. Even after eliminating these complications from our analysis, the mean NSQIPRC predicted rates were lower than the observed rates of serious complications ( 25% vs 34%), any complications (28% vs 35%), readmission (19% vs 27%), and reoperation (4% vs 6.5%) respectively. The NSQIPRC did not perform well with area under the ROC curve was (0.563) for serious complication, (0.551) for any complication, (0.515) for readmission, and (0.587) for reoperation. However, the calculator had acceptable prediction of mortality (c-statistic 0.729, Brier's score 0.02), and poor in predicting pneumonia (c-statistic 0.629, Brier's score 0.022) and deep venous thrombosis (c-statistic 0.625, Brier's score 0.032).
CONCLUSIONS: NSQIP risk factor calculator underestimates the probability of post-op morbidity. It underperforms in predicting the rates of serious complications, any complication, readmission, and reoperation. Nonetheless, it is reasonable in predicting mortality after surgery. Major improvements in data processing and calculator design are needed. INTRODUCTION AND OBJECTIVES: Robotic-assisted radical cystectomy (RARC) has become increasingly utilized in treatment of muscle-invasive bladder cancer, yet the limited data to support its oncologic efficacy comes largely from high volume centers. RARC represents a technically demanding procedure, and results may not be reproducible across multiple surgeons and institutions. We aim to assess the effect of center volume on survival outcomes in patients undergoing RARC.
Source of
METHODS: Using the National Cancer Data Base (NCDB) we identified patients undergoing RARC from 2010-2012. Center volume was defined by the number of RARC performed over the study period. Low volume centers were defined by <10 RARC, representing the lowest tertile. Univariable and multivariable regression modeling was Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e723
